United States · FDA National Drug Code directory
Duloxetine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 47335-382_cec0154d-5c8c-496d-89bd-ba2a93aee774
- Product NDC
- 47335-382
- Form
- CAPSULE, DELAYED RELEASE
- Composition / generic term
- Duloxetine
- Labeler
- Sun Pharmaceutical Industries, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20131211
- Source listing expiry
- 20261231
Source-listed ingredients
- DULOXETINE HYDROCHLORIDE — 30 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE, DELAYED RELEASE in 1 BOTTLE (47335-382-08) · 47335-382-08
- 1000 CAPSULE, DELAYED RELEASE in 1 BOTTLE (47335-382-18) · 47335-382-18
- 100 BLISTER PACK in 1 CARTON (47335-382-61) / 1 CAPSULE, DELAYED RELEASE in 1 BLISTER PACK · 47335-382-61
- 90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (47335-382-81) · 47335-382-81
- 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (47335-382-83) · 47335-382-83
- 100 CAPSULE, DELAYED RELEASE in 1 BOTTLE (47335-382-88) · 47335-382-88
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →